Thu 25 Jun 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| FEGONA (Fingolimod) | FEGONA (Fingolimod): Risk related to the effects of FEGONA on the immune system. |
||
| Fingolimod (Gilenya®) | Risks related to the effects on the immune system . |
||
| Xarelto ® (Rivaroxaban) | Warnings and precautions for use to reduce the risk of bleeding. |
||
| Motilium® (Domperidone) | New recommendations to minimise the cardiac risks . |
||
| Amistop® (Domperidone) | New recommendations to minimise the cardiac risks . |
||
| Mododom® (Domperidone) | New recommendations to minimise the cardiac risks . |
||
| Prokinin® (Domperidone) | New recommendations to minimise the cardiac risks . |
||
| Arzerra® (ofatumumab) | Safety update on a fatal infusion reaction reported in a patient with Chronic lymphocytic leukemia (CLL) who was treated with intravenous ofatumumab . |
||
| Arzerra® (ofatumumab) | change to safety information regarding update to hepatitis B virus reactivation warning . |
||
| Riacavilol® (Carvedilol) | Important safety update of prescribing information for Carvidol® (Carvedilol) |
Last update date: 21/04/2024 at 10:00 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.